NYSE: AMRZAmrize Ltd Stock
$50.25-2.75 (-5.19%)
Updated Jun 25, 2025
AMRZ Price
$50.25
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$48.30
52 Week High
$56.29
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1.38
Operating Cash Flow
N/A
Beta
6.41
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AMRZ's potential to beat the market
- AMRZ doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Building Material
Industry Rating
C
AMRZ
RankedUnranked of 15
RankedUnranked of 15
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $99.02 | B | |
| $74.71 | B | |
| $6.74 | B |
Be the first to know about important AMRZ news, forecast changes, insider trades & much more!
AMRZ News
Overview
Due Diligence Score
–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AMRZ scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AMRZ's short-term assets ($4.12B) exceed its short-term liabilities ($2.06B)
Short-term Liabilities Financials
AMRZ's long-term liabilities ($11.39B) exceed its short-term assets ($4.12B)
Long-term Liabilities Financials
AMRZ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
There are 30 more AMRZ due diligence checks available for Premium users.
Valuation
AMRZ's financial health
Profit margin
Revenue
$2.1B
Net Income
-$87.0M
Profit Margin
-4.2%
Assets to liabilities
Assets
$23.2B
Liabilities
$13.4B
Debt to equity
1.38
AMRZ's short-term assets ($4.12B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AMRZ's long-term liabilities ($11.39B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AMRZ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$856.0M
Investing
-$60.0M
Financing
-$97.0M
AMRZ vs Building Material Stocks
Amrize Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.